Far from a P&D - perform some effortless D&D on this gem and you'll soon see that is not a factual claim. Many of us longs have already done the work for you - just read the stickies on this message board. Ample proof that this company is performing beyond expectations YOY, despite the PPS not reflecting the true value of RXMD. They have delivered on 100% of the milestones they set forth thus far for 2017.
I highly suggest your listen in on the upcoming Conf Call next week. For an OTC company, soon to be an OTCQB company - they run the ship like a NASDAQ firm.
ZERO dilution occurring here. Share structure has been solid as a rock for nearly 12 months now.